Browsing by Author Gibson, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2013Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balanceBryant, Christian; Fromm, Phillip; Hart, Derek; Ho, Phoebe (Joy); Iland, Harry; Joshua, Douglas; Aklilu, Esther; Brown, Ross; Favaloro, James; Gibson, J; Nassif, N; Suen, Hayley; Woodland, N. B.; Yang, S; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineLong-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance, Blood Cancer Journal, vol.3, N/A, 2013,pp 1-7
2015Management of Systemic AL Amyloidosis: Recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupHo, Joy Phoebe; Augustson, B; Brown, R; Catley, Laurence; Douglas, Joshua; et al, Various; Gibson, J; Harrison, S; Horvath, N; Jaksic, W; Mollee, P.; Quach, H; Weber, N; Central Clinical School: MedicineManagement of Systemic AL Amyloidosis: Recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group, Internal Medicine Journal, vol.45, 4, 2015,pp 371-382
2015Phospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myelomaHart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Brown, R. D.; Gibson, J; Suen, Hayley; Weatherburn, Claire; Yang, S; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: MedicinePhospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myeloma, Leukemia, vol.29, 2, 2015,pp 483-490
2009Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma.Joshua, Douglas; Aklilu, Esther; Brown, R. D.; Gibson, J; Ho, Joy; Kabani, Karieshma; Kennedy, Nola; Spencer, Andrew; Sze, Daniel M.; Yang, Shihong; Central Clinical School: MedicinePrognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma., Leukemia and Lymphoma, vol.50, 11,pp 1860-1864
2007The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR studyBradstock, Kenneth; Cook, G; Feyler, S; Gibson, J; Marks, DI; Nivison-Smith, I; Patton, N; Pearce, R; Prince, H.Miles; Schey, S; Towlson, K; Western Clinical School: Westmead Millennium InstituteThe role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study, Bone Marrow Transplantation (2005), vol.40,(5),2007,pp 443-450